Acute Effects of Fibular Repositioning Taping on Balance, Jumping, and Sprint Performance

May 21, 2026 updated by: Selim Mahmut GÜNAY, Uludag University

The Acute Effect of Fibular Repositioning Taping on Balance, Jumping, and Sprint Performance in Healthy Individuals: A Randomized Controlled Trial

This randomized controlled trial aims to investigate the acute effects of fibular repositioning taping on balance, jumping, and sprint performance in healthy young women. Eligible participants are randomly allocated to one of three groups: fibular repositioning taping, sham taping, or control. Physical performance and dynamic balance are assessed at baseline and after the intervention using functional outcome measures, including jumping tests, a 10-meter sprint test, and the Y Balance Test. The study is designed to determine whether fibular repositioning taping produces short-term changes in selected performance parameters compared with sham taping and no intervention.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Selim M GÜNAY, Asst Prof
  • Phone Number: +90 539 462 8521
  • Email: mgselim1@gmail.com

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy individuals
  • Age between 18 and 30 years
  • Willingness to participate in the study and provide informed consent
  • Ability to perform balance, jump, and sprint performance tests

Exclusion Criteria:

  • History of lower extremity injury or surgery within the last 6 months
  • Presence of acute pain during testing
  • Neurological, orthopedic, or vestibular condition that may affect balance or performance
  • Previous experience of adverse reaction to taping material
  • Refusal to participate or inability to complete the study procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Fibular Repositioning Taping Group
Participants in this group receive fibular repositioning taping applied to the dominant ankle. Baseline assessments are performed before taping, and outcome measurements are repeated 30 minutes after the intervention.
Procedure: Fibular Repositioning Taping
Fibular repositioning taping is applied to the dominant ankle using a rigid taping technique intended to support fibular positioning. Outcome measurements are repeated 30 minutes after the application.
Sham Comparator: Sham Taping Group
Participants in this group receive a sham taping application with a similar appearance to the fibular repositioning taping but without therapeutic fibular repositioning. Baseline assessments are performed before taping, and outcome measurements are repeated 30 minutes after the application.
Procedure: Sham Taping
Sham taping is applied to the dominant ankle with a similar appearance to the active taping application but without therapeutic fibular repositioning or manual correction
No Intervention: Control Group
Participants in this group receive no taping intervention. Baseline assessments are performed, and outcome measurements are repeated after a 30-minute waiting period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Y Balance Test
Time Frame: Baseline and 30 minutes after the intervention
Dynamic balance will be assessed using the Y Balance Test. The composite score will be calculated from reach distances and normalized to limb length. Higher composite scores indicate better dynamic balance performance.
Baseline and 30 minutes after the intervention
Horizontal Jump Test
Time Frame: Baseline and 30 minutes after the intervention
Horizontal jump performance will be assessed using the Horizontal Jump Test. The jump distance will be measured in centimeters from the starting line to the landing point. Greater distance indicates better horizontal jump performance.
Baseline and 30 minutes after the intervention
10-Meter Sprint Test
Time Frame: Baseline and 30 minutes after the intervention
Sprint performance will be assessed using the 10-meter sprint test. The time required to complete the 10-meter sprint will be recorded in seconds. Shorter times indicate better sprint performance.
Baseline and 30 minutes after the intervention
Vertical Jump Test
Time Frame: Baseline and 30 minutes after the intervention
Vertical jump performance will be assessed using the Vertical Jump Test. Jump height will be measured in centimeters. Greater jump height indicates better vertical jump performance.
Baseline and 30 minutes after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Uludag University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 2, 2026

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

May 1, 2026

Study Registration Dates

First Submitted

April 29, 2026

First Submitted That Met QC Criteria

May 15, 2026

First Posted (Actual)

May 22, 2026

Study Record Updates

Last Update Posted (Actual)

May 27, 2026

Last Update Submitted That Met QC Criteria

May 21, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2025/819/15-10

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be made publicly available in order to protect participant privacy and confidentiality.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Balance

Clinical Trials on Fibular Repositioning Taping

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe